EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia

Rossana Maffei, Ambra Paolini, Benedetta Conte, Giovanni Riva, Vincenzo Nasillo, Federica Cretì, Silvia Martinelli, Francesca Giacobbi, Giorgia Corradini, Flora Pilato, Daniela Bernabei, Cesare Lancellotti und 20 weitere

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06232-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2025. Verfasst von Rossana Maffei und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, Azienda Ospedaliero-Universitaria, Policlinico, and AUS…. Hauptthemen laut MEDLINE: Receptors, Colony-Stimulating Factor, Mutation, Myeloproliferative Disorders. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Modena e Reggio Emilia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The colony-stimulating factor 3 receptor (CSF3R) plays an essential role in differentiation, growth, and survival of granulocytes. Driver mutations in CSF3R gene represent a diagnostic marker of chronic neutrophilic leukemia (CNL). Less commonly, these mutations are observed in other myeloid neoplasms but their pathogenetic and prognostic role is still unclear. Here, we analyzed a large cohort of myeloid neoplasms to evaluate the incidence of CSF3R mutations and co-mutational profile. Mutational analysis was performed using targeted NGS myeloid panel in a consecutive cohort of 360 patients with myeloid neoplasms. Mutations in CSF3R were identified in 20/360 (5.6%) cases. A CSF3R gene mutation was present in 13/179 AML cases (7.3%), in 2/27 (7.4%) CMML cases, in 1/94 (1.1%) MDS cases and in 4/60 (6.7%) other myeloid neoplasms. The frequencies of patients with CSF3R mutations lowered to 2.8% in all cases and 3.4% in AML, excluding cases with variants of uncertain significance (VUS). A total of 23 mutations of CSF3R gene were detected, half localized in the extracellular domain, 5 in the transmembrane region (type I) and 6 mutations in the cytoplasmic domain (type II). In AML, CSF3R mutations were more frequent in patients harboring CBF alterations (25.0%) and CEBPA mutations (11.8%). Two cases with AML harboring pathogenic CSF3R variants were primary refractory to induction therapy. CMML cases with T618I variant showed a myeloproliferative phenotype. Overall, our findings support the notion that CSF3R variants, particularly type I and II pathogenic mutations, may modulate the phenotypic features of leukemic cells in myeloid neoplasia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Colony-Stimulating FactorMutationMyeloproliferative DisordersHumansMaleFemaleAgedMiddle AgedAdultAged, 80 and overDNA Mutational AnalysisLeukemia, Myeloid, AcuteLeukemia, Neutrophilic, ChronicCohort Studies

Stichwörter der Autor:innen

CSF3RCo-mutational patternDisease outcomeMyeloid neoplasia

Substanzen

CSF3R protein, humanReceptors, Colony-Stimulating Factor

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, Azienda Ospedaliero-Universitaria, Policlinico, and AUSL Modena, Italy. rossana.maffei@unimore.it.
  • Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, Azienda Ospedaliero-Universitaria, Policlinico, and AUSL Modena, Italy.
  • Hematology Unit, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria, Policlinico, Modena, Italy.
  • Pathology Unit, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria, Policlinico, Modena, Italy.
  • Interdepartmental Centre for Stem Cells and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Förderung

  • Università degli Studi di Modena e Reggio Emilia

Zitieren

APA

Maffei, R., Paolini, A., Conte, B., Riva, G., Nasillo, V., Cretì, F., Martinelli, S., Giacobbi, F., Corradini, G., Pilato, F., Bernabei, D., Lancellotti, C., Debbia, G., Morselli, M., Potenza, L., Giusti, D., Colaci, E., Bettelli, F., Bresciani, P., …, & Tagliafico, E. (2025). Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia. Annals of Hematology. https://doi.org/10.1007/s00277-025-06232-1

Vancouver

Maffei R, Paolini A, Conte B, Riva G, Nasillo V, Cretì F, et al. Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia. Annals of Hematology. 2025. doi:10.1007/s00277-025-06232-1

BibTeX
@article{Maffei2025,
  author = {Maffei, Rossana and Paolini, Ambra and Conte, Benedetta and Riva, Giovanni and Nasillo, Vincenzo and Cretì, Federica and Martinelli, Silvia and Giacobbi, Francesca and Corradini, Giorgia and Pilato, Flora and Bernabei, Daniela and Lancellotti, Cesare and Debbia, Giulia and Morselli, Monica and Potenza, Leonardo and Giusti, Davide and Colaci, Elisabetta and Bettelli, Francesca and Bresciani, Paola and Cuoghi, Angela and Gilioli, Andrea and Messerotti, Andrea and Pioli, Valeria and Maccaferri, Monica and Leonardi, Giovanna and Manfredini, Rossella and Marasca, Roberto and Eccher, Albino and Luppi, Mario and Forghieri, Fabio and Candoni, Anna and Tagliafico, Enrico},
  title = {Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06232-1}
}
Kostenlos starten →